Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures.

Mol Autism 2015 21;6:66. Epub 2015 Dec 21.

Department of Biomedical Informatics, Harvard Medical School, Boston, MA USA ; Children's Hospital Informatics Program, Boston Children's Hospital, Boston, MA USA ; Department of Pediatrics, Harvard Medical School, Boston, MA USA.

Background: Fragile X syndrome (FXS) is a neurodevelopmental disorder whose biochemical manifestations involve dysregulation of mGluR5-dependent pathways, which are widely modeled using cultured neurons. In vitro phenotypes in cultured neurons using standard morphological, functional, and chemical approaches have demonstrated considerable variability. Here, we study transcriptomes obtained in situ in the intact brain tissues of a murine model of FXS to see how they reflect the in vitro state.

Methods: We used genome-wide mRNA expression profiling as a robust characterization tool for studying differentially expressed pathways in fragile X mental retardation 1 (Fmr1) knockout (KO) and wild-type (WT) murine primary neuronal cultures and in embryonic hippocampal and cortical murine tissue. To study the developmental trajectory and to relate mouse model data to human data, we used an expression map of human development to plot murine differentially expressed genes in KO/WT cultures and brain.

Results: We found that transcriptomes from cell cultures showed a stronger signature of Fmr1KO than whole tissue transcriptomes. We observed an over-representation of immunological signaling pathways in embryonic Fmr1KO cortical and hippocampal tissues and over-represented mGluR5-downstream signaling pathways in Fmr1KO cortical and hippocampal primary cultures. Genes whose expression was up-regulated in Fmr1KO murine cultures tended to peak early in human development, whereas differentially expressed genes in embryonic cortical and hippocampal tissues clustered with genes expressed later in human development.

Conclusions: The transcriptional profile in brain tissues primarily centered on immunological mechanisms, whereas the profiles from cell cultures showed defects in neuronal activity. We speculate that the isolation and culturing of neurons caused a shift in neurological transcriptome towards a "juvenile" or "de-differentiated" state. Moreover, cultured neurons lack the close coupling with glia that might be responsible for the immunological phenotype in the intact brain. Our results suggest that cultured cells may recapitulate an early phase of the disease, which is also less obscured with a consequent "immunological" phenotype and in vivo compensatory mechanisms observed in the embryonic brain. Together, these results suggest that the transcriptome of cultured primary neuronal cells, in comparison to whole brain tissue, more robustly demonstrated the difference between Fmr1KO and WT mice and might reveal a molecular phenotype, which is typically hidden by compensatory mechanisms present in vivo. Moreover, cultures might be useful for investigating the perturbed pathways in early human brain development and genes previously implicated in autism.

Download full-text PDF

Source
http://www.molecularautism.com/content/6/1/66
Publisher Site
http://dx.doi.org/10.1186/s13229-015-0061-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687343PMC
December 2015
10 Reads

Publication Analysis

Top Keywords

primary neuronal
12
cultured neurons
12
cortical hippocampal
12
differentially expressed
12
human development
8
expressed genes
8
cultures
8
cell cultures
8
neuronal cultures
8
early human
8
fmr1ko cortical
8
hippocampal tissues
8
signaling pathways
8
intact brain
8
brain tissue
8
brain tissues
8
compensatory mechanisms
8
fmr1ko mice
8
brain
7
fmr1ko
6

References

(Supplied by CrossRef)

MF Bear et al.
Trends Neurosci 2004

AL Bhakar et al.
Annu Rev Neurosci 2012

SD Koukoui et al.
Brain Res Rev 2007

KM Huber et al.
Proc Natl Acad Sci U S A 2002

G Dolen et al.
Neuron 2007

G Dolen et al.
Pharmacol Ther 2010

DD Krueger et al.
Annu Rev Med 2011

LN Antar et al.
Mol Cell Neurosci 2006

R Galvez et al.
Am J Med Genet A 2005

SA Irwin et al.
Am J Med Genet 2001

EA Nimchinsky et al.
J Neurosci 2001

Similar Publications